MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 239 filers reported holding MEDICINES CO in Q2 2019. The put-call ratio across all filers is 1.08 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $18,000 | +80.0% | 209 | 0.0% | 0.00% | – |
| Q3 2019 | $10,000 | +900.0% | 209 | +674.1% | 0.00% | – |
| Q2 2019 | $1,000 | 0.0% | 27 | 0.0% | 0.00% | – |
| Q1 2019 | $1,000 | -99.9% | 27 | -99.9% | 0.00% | -100.0% |
| Q4 2017 | $749,000 | -22.5% | 27,406 | +5.1% | 0.03% | -25.7% |
| Q3 2017 | $966,000 | -1.0% | 26,068 | +1.4% | 0.04% | -7.9% |
| Q2 2017 | $976,000 | -20.3% | 25,697 | +2.6% | 0.04% | -22.4% |
| Q1 2017 | $1,224,000 | +51.5% | 25,034 | +5.2% | 0.05% | +44.1% |
| Q4 2016 | $808,000 | -9.9% | 23,802 | +0.1% | 0.03% | -12.8% |
| Q3 2016 | $897,000 | +12.4% | 23,767 | +0.2% | 0.04% | +11.4% |
| Q2 2016 | $798,000 | +7.3% | 23,718 | +1.2% | 0.04% | +6.1% |
| Q1 2016 | $744,000 | -15.0% | 23,430 | 0.0% | 0.03% | -17.5% |
| Q4 2015 | $875,000 | +266.1% | 23,430 | +272.1% | 0.04% | +233.3% |
| Q3 2015 | $239,000 | -49.3% | 6,297 | -61.8% | 0.01% | -42.9% |
| Q2 2015 | $471,000 | +2.2% | 16,464 | 0.0% | 0.02% | 0.0% |
| Q1 2015 | $461,000 | – | 16,464 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,778,742 | $138,680,000 | 22.51% |
| Sarissa Capital Management LP | 1,922,000 | $70,537,000 | 14.14% |
| Antipodean Advisors LLC | 165,500 | $6,074,000 | 7.66% |
| Boxer Capital, LLC | 1,250,000 | $45,875,000 | 5.19% |
| BRIDGER MANAGEMENT, LLC | 2,604,965 | $95,602,000 | 5.18% |
| Slate Path Capital LP | 1,730,000 | $63,491,000 | 4.80% |
| HighVista Strategies LLC | 268,240 | $9,844,000 | 4.44% |
| Camber Capital Management LP | 2,000,000 | $73,400,000 | 2.82% |
| Lion Point Capital, LP | 727,205 | $26,688,000 | 2.40% |
| THREE BAYS CAPITAL LP | 1,360,560 | $49,933,000 | 1.94% |